Photodynamic diagnosis for upper urinary tract carcinoma using 5-ALA

Photodynamic diagnosis for upper urinary tract carcinoma using 5-ALA - PDD for UUTC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031616

Enrollment

Registered

2018-04-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper urinary tract carcinoma

Interventions

Photodynaminc diagnosis for upper urinary tract carcinoma after ALA administration. ALA: 20mg/kg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age-lower limit; >20 year-old 2. Suspicious of upper urinary tract carcinoma 3. To agree informed concent 4. To sign agreement document

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity for ALA 2. Porphyria patients 3. Severe infectious disease 4. Severe complication

Design outcomes

Primary

Measure	Time frame
Positive subject rates	—

Secondary

Measure	Time frame
Sensitivity, specificity	—

Countries

Japan

Contacts

Public ContactFukuhara Hideo

Kochi medical school Department of urology

jm-fukuhara@kochi-u.ac.jp088-880-2402

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026